News

Prof. Jennifer Hundt was elected to the board for the next four years at the 50th ADF conference in Düsseldorf (06.03.2024 - 09.03.2024). We…

Read more

We congratulate PD Dr. rer. nat. Stephanie Goletz, who completed her habilitation at the University of Lübeck in the field of Experimental Dermatology

Read more

 Schmidt E. (Ed.), Springer, 2021 | link.springer.com/978-3-030-82804-2
 

  • Details the latest diagnosis and management options available for…
Read more

 Boch et al, Lichen planus. Front. Med., 01 November 2021 | doi

Abstract:

Lichen planus (LP) is a T cell-mediated disease affecting the stratified…

Read more

 The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study

Kridin et al, J Am Acad Dermatol. 2021 Mar…

Read more

Abstract:

Several genetic variants in the mitochondrial genome (mtDNA), including ancient polymorphisms, are associated with chronic inflammatory…

Read more

New paper in Front Immunol.

Abstract:

Pemphigus and pemphigoid diseases are autoimmune bullous diseases characterized and caused by autoantibodies…

Read more

Abstract:

Background: Bullous pemphigoid (BP) and asthma both share a pathogenic role of eosinophils and immunoglobulin E (IgE) and favorable…

Read more

New paper by LIED researcher in Dermatology

Abstract:

Background: Ulcerative colitis (UC) is a well-known underlying comorbidity of pyoderma…

Read more

New paper in Arch Dermatol Res.

Abstract:

The association between bullous pemphigoid (BP) and melanoma is yet to be investigated. We aimed to assess…

Read more

Together with an international researcher consortium headed by David Granville (University of British Columbia), LIED researchers contributed to…

Read more

Preclinicaltrials aims to provide a comprehensive listing of preclinical animal study protocols. Preferably registered at inception in order to…

Read more

Study with participation of the Excellence Cluster "Precision Medicine in Chronic Inflammation" shows for the first time link between genetics, gut…

Read more

Multiethnic differences: genetic risk factors cannot simply be transferred from one population to another

Abstract: A small number of de novo…

Read more

Identification of novel therapeutic targets for blocking acantholysis in pemphigus

Br J Pharmacol. 2020 Aug 19. doi: 10.1111/bph.15233. 

 

Backgroun…

Read more

Alterations of total serum immunoglobulin concentrations in pemphigus and pemphigoid: Selected IgG2 deficiency in bullous pemphigoid

Front. Med. |…

Read more

Is Gout Associated with Pyoderma Gangrenosum? A Population-Based Case-Control Study. J Clin Med. 2020 May 28;9(6):E1626

Quantification of the…

Read more

Dupilumab for treatment-refractory prurigo nodularis. J Dtsch Dermatol Ges. 2020 Jun;18(6):618-624

Read more

Impact of diet and genes on murine autoimmune pancreatitis. J Cell Mol Med. 2020 Jul 8. doi: 10.1111/jcmm.15540

Read more

Long-term Outcomes of Rituximab Therapy in Pemphigus J Eur Acad Dermatol Venereol

​​​​​​Low prevalence of late-onset neutropenia following rituximab…

Read more

Nature Communicationsvolume 10, Article number: 4097 (2019)

Read more

A collection of well-over 80 articles covering all aspects of autoantibodies in one Ebook, edited by international key opinion leaders in the…

Read more

Anti-neonatal Fc Receptor (FcRn) Antibody Treatment Ameliorates Experimental Epidermolysis Bullosa Acquisita in Mice

Read more

The Spring Retreat 2020 will take place on April 28th on the campus in Lübeck.

Read more

Kasprick A, Bieber K, Ludwig RJ. Drug Discovery for Pemphigoid Diseases. Curr Protoc Pharmacol. 2019 Feb 20:e55. doi: 10.1002/cpph.55


Koga H,…

Read more

The Autumn Retreat 2019 is scheduled on November 7 and 8 (Thursday and Friday) and will take place in the Vitalia hotel in Bad Segeberg.

Read more

Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients


Read more

Results published in Frontiers in Immunology:

Therapeutic effect of a novel PI3Kδ inhibitor in experimental epidermolysis bullosa acquisita …

Read more

 

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018 Apr…

Read more